Research.Patient.info
Epithelial Ovarian Cancer research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE3
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
This study is for women with advanced ovarian cancer who've had their first treatment. It's testing if two medications, rucaparib and nivolumab, given after initial treatment, can help prevent the cancer from returning or growing. It compares these drugs to dummy treatments.
United States · Australia · Belgium - active not recruitingPHASE3
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
This study looks at whether Olaparib tablets can help women with advanced ovarian cancer that has a specific genetic change (BRCA mutation) after their initial chemotherapy, aiming to keep the cancer from returning for longer.
United States · Australia · Brazil